Nanotechnology or Nano medicine has been identified as the dominant and most
commercially invented technology that aims to improve the quality of health care strategies …

Multidrug resistance (MDR) is the phenomenon in which cancer cells simultaneously
develop resistance to a broad spectrum of structurally and mechanistically unrelated drugs …

Chemotherapy is currently the main treatment for unresectable or advanced postoperative
gastric cancers. However, its efficacy is negatively affected by the occurrence of …

Gastric cancer is the third most common cause of cancer-related death worldwide. Drug
resistance is the main inevitable and vital factor leading to a low 5-year survival rate for …

Gastric cancer (GC) is a leading type of cancer. Although immunotherapy has yielded
important recent progress in the treatment of GC, the prognosis remains poor due to drug …

Metallothioneins (MTs) are small cysteine-rich intracellular proteins with four major isoforms
identified in mammals, designated MT-1 through MT-4. The best known biological functions …

Gastric cancer (GC) is turning out today to be one of the most important welfare issues for
both Asian and European countries. Indeed, while the vast majority of the disease burden is …

Gastric adenocarcinoma (GAC) is the most common histological type of gastric cancer, the
fifth according to the frequency and the third among the deadliest cancers. GAC high …

Chemotherapy and targeted therapy can significantly improve survival rates in cancer, but
multiple drug resistance (MDR) limits the efficacy of these approaches. Understanding the …

Gastric cancer remains a serious health burden with few therapeutic options. Therefore, the
recognition of cancer stem cells (CSCs) as seeds of the tumorigenic process makes them a …